Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

First, it's difficult for the cancer hunters to get inside a tumor. Second, not all the cancer cells necessarily have the structure the T-cells can recognize and attack. And third, solid tumors in ...

Scientists uncovered a previously unrecognized tumor suppression mechanism through the study of condensates and ribosome formation.

The Mattiroli group's researchers discovered that the speed at which DNA is replicated during cell division can be directly ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

But a new proof-of-concept study from Fred Hutch Cancer Center scientists, published in September in Cell Reports, suggests a ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in ...

In addition to these three clinical programs, Cullgen is also advancing several other targeted protein degraders and DACs, predominantly for the treatment of cancer and autoimmune disease, including a ...

The ability to manipulate the structure of hydrogels in this way would enable ... solid tissues and testing treatments to ...

In an encounter, Delhi Police Special Cell arrested shooter Mogli who is a gangster of Deepak Boxer Gogi gang. Shooter Mogli ...